JBM (Healthcare) Limited (HKG:2161)

Hong Kong · Delayed Price · Currency is HKD

2.000

+0.010 (0.50%)

Jul 13, 2026, 11:35 AM HKT

Revenue by Segment

Financials in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Branded Medicines	279.97M	272.23M	190.11M	124.04M	134.33M
Branded Medicines Growth	2.84%	43.20%	53.26%	-7.66%	-0.11%
Health and Wellness Products	86.26M	104.61M	72.19M	36.52M	38.90M
Health and Wellness Products Growth	-17.55%	44.92%	97.67%	-6.13%	-24.93%
Proprietary Chinese Medicines	468.40M	405.45M	386.12M	359.77M	232.91M
Proprietary Chinese Medicines Growth	15.53%	5.01%	7.33%	54.47%	10.46%
Total	834.63M	782.29M	648.42M	520.32M	406.14M
Total Growth	6.69%	20.65%	24.62%	28.11%	2.26%

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Hong Kong	697.52M	562.01M	462.83M	331.89M	284.61M
Hong Kong Growth	24.11%	21.43%	39.45%	16.61%	-5.21%
Mainland China	67.84M	146.98M	128.43M	135.25M	61.01M
Mainland China Growth	-53.84%	14.45%	-5.05%	121.68%	119.39%
Macau	21.96M	38.64M	25.85M	26.42M	35.87M
Macau Growth	-43.17%	49.49%	-2.15%	-26.34%	-23.02%
Singapore	24.03M	15.56M	12.51M	9.77M	12.38M
Singapore Growth	54.42%	24.43%	28.04%	-21.09%	153.51%
Others	23.28M	19.10M	18.80M	17.00M	12.27M
Others Growth	21.87%	1.58%	10.63%	38.50%	-30.37%
Total	834.63M	782.29M	648.42M	520.32M	406.14M
Total Growth	6.69%	20.65%	24.62%	28.11%	2.26%